Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Halaman 1 dari 20 hasil
Anti-inflammatory effect of microfibrillated cellulose
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CLAIM OF PRIORITY
This application claims priority under 35 USC 371 to International Application No. PCT/FI2012/050129, filed on Feb. 10, 2012, which claims priority to Finland Application Serial No. 20115135, filed Feb. 11, 2011, each of which is incorporated by reference in its entirety.
FIELD OF
Preparation for prevention and healing of inflammation affections
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of PCT/CZ98/00046 filed Oct. 2, 1998.
TECHNICAL FIELD
The invention relates to a preparation for prevention and healing of inflammation affections having a radical scavenging capacity with a large biological spectrum coverage. The preparation is applicable to the prevention
Ophthalmological composition of matter and a method for treatment of ocular inflammation by said composition
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
DESCRIPTION:
The present invention relates to a new ophthalmological composition, the active ingredient of which is eicosapentaenoic acid.
Eicosapentaenoic acid, abbreviated hereafter as "EPA", means cis-5, 8, 11, 14, 17-eicosapentaenoic acid of the formula ##STR1##
EPA is a known polyunsaturated
Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
The present invention relates to an improved pharmaceutical formulation for indomethacin and more particularly relates to a solid dosage, constant order release indomethacin formulation.
The number of people who have arthritis is increasing. It is currently estimated that
Bioadhesive extruded film for intra-oral drug delivery and process
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a controlled-releasing medicament-containing preparation for intra-oral use, and is more especially concerned with such a preparation (and the process of using it) in the form of a very thin extruded thermoplastic
Nutritional composition
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to a nutrient composition (nutritional composition) having lipid metabolism-improving action. The nutrient composition highly effectively contributes to decrease of neutral lipids (triglycerides). The nutrient composition is expected to offer
Stable aqueous suspension
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to a novel aqueous pharmaceutical suspension for homogeneously suspending at least one non-steroidal anti-inflammatory drug, a method of their production and their use in the treatment of disease, especially inflammatory diseases in humans and animals.
Numerous
Spheroids
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to a controlled release pharmaceutical composition containing a water-insoluble drug for administration to humans and/or animals.
In the present specification the term "spheroid" means a spherical granule having a diameter of between 0.5mm and 2.5mm, especially between
Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a powdery pharmaceutical composition suitable for application to the mucosa of the oral or nasal cavity. More specifically, it relates to a powdery pharmaceutical composition, suitable for application to the
Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD
The present invention is directed to the prevention or reduction of postoperative ileus and gastric stasis.
BACKGROUND
Ileus is a major complication following abdominal surgery, and especially an abdominal surgery that involves manipulating the intestines and other abdominal organs.
Oral care composition for enhancing delivery of active agents to mucosa/soft oral tissue and tooth surfaces in the oral cavity
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of International Application No. PCT/EP2012/075082, filed Dec. 11, 2012, which claims the priority of GB Application No. GB 1121300.3 filed Dec. 12, 2011, which is incorporated herein in its entirety.
FIELD OF THE INVENTION
The present invention relates to oral care
Methods and compositions for rapid treatment of otitis externa
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to non-invasive methods and compositions for treating otitis externa (outer ear infection or infestation and inflammation) without use of a cellulose viscocity-enhancing component, gel or adhesive-based formulation.
BACKGROUND OF THE
Absorbable composite materials for use in the treatment of periodontal disease
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to absorbable composite materials in the form of a strip or film that are specially adapted for the treatment of periodontal disease.
"Periodontal disease" is the term commonly used to describe inflammatory disease of the periodontium (tooth-surrounding tissue). It is a
Skin treating composition
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to a skin treating composition containing vitamin E; a blend comprising acetylated monoglyceride and polyoxyethylene fatty acid ester; a blend comprising distilled monoglyceride, distilled propylene glycol monoester, and sodium or calcium stearoyl
Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
This invention relates to orally administered low dose, topically acting corticosteroid compositions, useful for the treatment of conditions associated with inflammation of the esophagus.
BACKGROUND OF THE INVENTION
Esophageal inflammation disorders such as eosinophilic
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
